Wei Qi Lin

Title: **Innovator Spotlight: Wei Qi Lin**

Introduction

Wei Qi Lin, a promising inventor based in Palo Alto, California, has made significant contributions to the field of transdermal drug delivery. With one patented innovation to his name, Lin is a vital asset to Alza Corporation, where he applies his expertise to enhance medical technologies.

Latest Patents

Lin's patented invention is titled “Methods for inhibiting decrease in transdermal drug flux by inhibition of pathway closure.” This groundbreaking patent addresses a method for preventing a decline in the transdermal flux of agents during prolonged delivery or sampling. By disrupting the stratum corneum layer of the skin to create pathways for the agent, Lin's method ensures effective delivery. The innovation includes co-delivering or co-sampling the agent with an effective amount of at least one anti-healing agent, thus maintaining the desired transdermal flux over time.

Career Highlights

Wei Qi Lin has established himself as a leading figure in the field of pharmaceutical inventions. Working with Alza Corporation, a company known for its innovative approaches to drug delivery systems, Lin has furthered the understanding and development of transdermal applications. His work is not only recognized for its technical relevance but also for its potential to improve patient outcomes through enhanced drug delivery mechanisms.

Collaborations

At Alza Corporation, Lin collaborates with talented colleagues, including Michel J Cormier and Juanita A Johnson. Together, they contribute to the innovative culture of the company, working on complex projects aimed at revolutionizing the pharmaceutical landscape through advanced delivery systems.

Conclusion

Wei Qi Lin stands out as a dedicated inventor with a clear focus on improving healthcare through his work on transdermal drug delivery. His patented method marks a significant advancement in the field and exemplifies the innovative spirit of Alza Corporation. As he continues to develop new solutions, Lin’s contributions will undoubtedly influence the future of pharmaceuticals and patient care.